Biosenic SA [BIOS] vs European Medical [ALEMS] Detailed Stock Comparison

Biosenic SA

EURONEXT
Loading...

European Medical Solutions S.à r.l.

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Biosenic SA wins in 1 metrics, European Medical Solutions S.à r.l. wins in 12 metrics, with 1 ties. European Medical Solutions S.à r.l. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Biosenic SA European Medical Solutions S.à r.l. Better
P/E Ratio (TTM) 0.00 11.14 Tie
Price-to-Book Ratio N/A 1.72 N/A
Debt-to-Equity Ratio -1.15 154.89 European Medical Solutions S.à r.l.
PEG Ratio -0.04 N/A N/A
EV/EBITDA -5.09 7.37 European Medical Solutions S.à r.l.
Profit Margin (TTM) 0.00% 3.46% European Medical Solutions S.à r.l.
Operating Margin (TTM) -70,700.00% 4.82% European Medical Solutions S.à r.l.
EBITDA Margin (TTM) N/A 4.82% N/A
Return on Equity 126.75% 16.43% Biosenic SA
Return on Assets (TTM) -46.20% 3.12% European Medical Solutions S.à r.l.
Free Cash Flow (TTM) $-3.47M $2.49M European Medical Solutions S.à r.l.
1-Year Return -80.00% 18.18% European Medical Solutions S.à r.l.
Price-to-Sales Ratio (TTM) -0.60 0.39 European Medical Solutions S.à r.l.
Enterprise Value $24.46M $34.52M European Medical Solutions S.à r.l.
EV/Revenue Ratio -10.25 0.65 European Medical Solutions S.à r.l.
Revenue per Share (TTM) $0 $13 European Medical Solutions S.à r.l.
Earnings per Share (Diluted) $-0.02 $0.44 European Medical Solutions S.à r.l.
Beta (Stock Volatility) -1.67 N/A N/A

Biosenic SA vs European Medical Solutions S.à r.l. Stock Performance Analysis

Loading Price Chart...

BIOS
ALEMS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Biosenic SA0.00%N/AN/AN/AN/AN/A
European Medical Solutions S.à r.l.-5.00%8.79%-0.95%-4.41%0.00%11.11%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Biosenic SA-80.00%-98.25%-99.73%-99.94%-98.97%-98.97%
European Medical Solutions S.à r.l.18.18%-26.14%-96.21%-99.78%-99.78%-99.78%

Performance & Financial Health Analysis: Biosenic SA vs European Medical Solutions S.à r.l.

MetricBIOSALEMS
Market Information
Market Cap i€1.57M€20.74M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i987,45320
90 Day Avg. Volume i872,48730
Last Close€0.00€4.94
52 Week Range€0.00 - €0.00€4.20 - €5.75
% from 52W High-37.50%-14.09%
All-Time High€28.90 (Feb 09, 2015)€2,956.45 (Feb 27, 2017)
% from All-Time HighN/A-99.83%
Growth Metrics
Quarterly Revenue Growth-1.00%0.13%
Quarterly Earnings GrowthN/A3.63%
Financial Health
Profit Margin (TTM) i0.00%0.03%
Operating Margin (TTM) i-707.00%0.05%
Return on Equity (TTM) i1.27%0.16%
Debt to Equity (MRQ) i-1.15154.89
Cash & Liquidity
Book Value per Share (MRQ)€-0.04€2.85
Cash per Share (MRQ)€0.00€1.16
Operating Cash Flow (TTM) i€-1,823,000€5.38M
Levered Free Cash Flow (TTM) i€-3,465,125€1.97M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Biosenic SA vs European Medical Solutions S.à r.l.

MetricBIOS (Apr 22, 2026)ALEMS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i0.0011.14
Forward P/E i-0.04N/A
PEG Ratio i-0.04N/A
Price to Sales (TTM) i-0.600.39
Price to Book (MRQ) iN/A1.72
Market Capitalization
Market Capitalization i€1.57M€20.74M
Enterprise Value i€24.46M€34.52M
Enterprise Value Metrics
Enterprise to Revenue i-10.250.65
Enterprise to EBITDA i-5.097.37
Risk & Other Metrics
Beta i-1.67N/A
Book Value per Share (MRQ) i€-0.04€2.85

Financial Statements Comparison: Biosenic SA vs European Medical Solutions S.à r.l.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBIOS (2023)ALEMS (2025)
Revenue/Sales i049.92M
Cost of Goods Sold iN/A33.48M
COGS % of Revenue i-67.1%
Gross Profit iN/A16.45M
Gross Margin i-32.9%
Research & Development i3.93MN/A
Operating Income (EBIT) i-7.04M2.68M
Operating Margin i-5.4%
EBITDA i-7.99M4.83M
EBITDA Margin i-9.7%
Pre-Tax Income i-29.03M1.91M
Pre-Tax Income % of Revenue i-3.8%
Income Tax i-7,00065,000
Income Tax % of Revenue i-0.1%
Net Income (Profit) i-29.02M1.84M
Profit Margin i-3.7%

Balance Sheet & Liquidity Metrics

MetricBIOS (2023)ALEMS (2025)
Cash & Equivalents i117,0004.89M
Total Current Assets i1.85M36.51M
Total Current Assets % of Revenue i-73.1%
Total Current Liabilities i15.84M25.59M
Total Current Liabilities % of Revenue i-51.3%
Long-Term Debt i16.34M10.17M
Long-Term Debt % of Revenue i-20.4%
Total Shareholders Equity i-22.71M12.06M
Retained Earnings i-34.89M1.84M
Retained Earnings % of Revenue i-3.7%
Property, Plant & Equipment i56,0006.21M

Cash Flow Statement Comparison

MetricBIOS (2023)ALEMS (2025)
Operating Cash Flow i-7.01M567,000
Operating Cash Flow % of Revenue i-1.1%
Capital Expenditures i6,000-2.88M
Free Cash Flow i-3.47M2.49M
FCF Margin i-5.0%
Debt Repayment i-413,000-6.25M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBIOSALEMS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i251.31M4.23M
Float Shares i603.17MN/A
% Held by Insiders i14.14%90.75%
% Held by Institutions i1.87%0.02%
% Held by Public i83.99%9.23%

Dividend Analysis & Yield Comparison: Biosenic SA vs European Medical Solutions S.à r.l.

MetricBIOSALEMS
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A